Skip to content

TruSpine Technolgs. - Further re Bridge Loan Facility & Letter of Intent


Announcement provided by

TruSpine Technologies Plc · TSP

20/02/2023 07:00

TruSpine Technolgs. - Further re Bridge Loan Facility & Letter of Intent
RNS Number : 3661Q
TruSpine Technologies PLC
20 February 2023
 

 

 

 

 

20 February 2023

 

 

TruSpine Technologies plc

("TruSpine" or the "Company")

 

Further re Bridge Loan Facility and Letter of Intent

 

 

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, provides an update in relation to the announcement released on 8 February 2023 concerning the expected receipt of funding from the Bridge Loan facility and the subscription for Tranche 1 of the staged equity funding under the LOI entered into with the Investment Group.

 

Funding from the Bridge Loan facility has not yet been received by the Company, however the Directors believe, based on discussions with the Investment Group, that the funds will be forthcoming in due course and the subscription for Tranche 1 of the staged equity funding is expected to be subscribed for on or before 1 March 2023. However, there is no guarantee that the funds from the Bridge Loan facility or from the Tranche 1 subscription will complete successfully.

 

As previously notified, in the event that the Bridge Loan facility does not complete successfully and the equity drawdown funds are not received, the Company will need to raise further capital in the short term. The Company continues to carefully manage its working capital and its financial position remains weak and is dependent on the goodwill of its creditors to continue trading. A further announcement will be made in due course.

 

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Company's announcement of 3 January 2023.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

 

Enquiries:

TruSpine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO




Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti


 
Oberon Capital (Joint Broker)

 
Tel: +44 (0)20 3179 5300

Mike Seabrook / Chris Crawford 


Peterhouse Capital Limited (Joint Broker & Financial Adviser)

 
Tel: +44 (0)20 7469 0930

Lucy Williams / Duncan Vasey

 


Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

truspine@walbrookpr.com

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAAANFLPDEAA ]]>

View more ...

TSP announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal